The second of three panel discussions at this year’s Astellas Patient Advocacy Summit entitled “Where is the Patient Voice in the Value Frameworks?” discussed new approaches to developing medicines while integrating the patient voice. Emily Wheeler, senior director of Astellas therapeutic area government strategy, Lori Kelly, executive vice president of PhRMA and Rick Chapman, director of health and economics at the Institute for Clinical and Economic Growth were all involved in the debate. Watch highlights from the discussion here.

Value Frameworks: How Best to Insert the Patient Voice Into Healthcare Decision Making

Astellas Patient Advocacy is a function within Corporate Affairs at Astellas that focuses on creating, building and maintaining third-party relationships. We serve as a conduit between Astellas and external stakeholders to help improve patient outcomes, improve access issues and address patients’ unmet needs head on.